The HemoSphere monitor helps you stay ahead of critical moments. For individualized patient management across a diversity of patient profiles and care settings, HemoSphere monitor offers compatibility with a range of sensors and catheters.
Now, with the ForeSight tissue oximetry sensor, you have access to a comprehensive view of tissue oximetry and advanced hemodynamics on one monitor to help ensure your patient is adequately perfused.
We are committed to evolving our solutions to enhance your experience. Our technical bulletins summarize the latest developments and enhancements on your monitoring platform. These bulletins will be periodically updated throughout the year to keep you informed.
ForeSight tissue oximetry integration:
- Delivers accurate performance in tissue oximetry with a confident decision and a variation range of approximately +/‐ 3.05%*. ForeSight sensor accounts for a range of tissue and skin tones and gives you oxygenation insights you can act on.
Acumen IQ sensor interface enhancements:
- Streamlined screen layout enhances focus on arterial pressure and select key dynamic parameters.
Cybersecurity and system improvements:
- Added Improvements to security controls as part of a continual process to manage cybersecurity risk across our various product lines and execute our cybersecurity post-market product surveillance and support program.
Notable resolved issues
User navigation workflows:
- Resolved issue with key parameters changing on Focus screens.
Applicable software versions
Software release notes can be accessed at http://eifu.edwards.com.
An Edwards Representative will schedule a time to update your hospital monitors with the latest updates. If you would like to learn more, please contact your Edwards Sales Representative or call Edwards Technical Support: +8001 8001 801.
For a view of our full product offerings Visit our hemodynamic monitoring page.
For more than 50 years, Edwards Lifesciences has been helping you make proactive clinical decisions and advance the care of surgical and acutely ill patients across the continuum of care. We are committed to evolving our solutions to expand the benefits of advanced hemodynamic monitoring to more patients, with a goal of improving care for 25 million patients per year by 2025.
For professional use
For a listing of indications, contraindications, precautions, warnings, and potential adverse events, please refer to the Instructions for Use (consult eifu.edwards.com where applicable).
Edwards Lifesciences devices placed on the European market meeting the essential requirements referred to in Article 3 of the Medical Device Directive 93/42/EEC bear the CE marking of conformity.
Please update to a current version of your preferred browser, this site will perform effectively on the following:Unable to update your browser?
If you are on a computer, that is maintained by an admin and you cannot install a new browser, ask your admin about it. If you can't change your browser because of compatibility issues, think about installing a second browser for browsing and keep this old one for compatibility